Tag Archives: About

Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What about the Opdivo combo?

Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent from rival Bristol Myers Squibb would offer additional benefit. Turns out, doing that adds more harm and no good. Merck decided to stop adding Bristol Myers’ CTLA-4 inhibitor Yervoy to Keytruda in… Read More »

Drugmakers seek to reassure public on coronavirus vaccine as concerns grow about political pressure

Lisa Taylor receives a COVID-19 vaccination from RN Jose Muniz as she takes part in a vaccine study at Research Centers of America on August 07, 2020 in Hollywood, Florida. Joe Raedle | Getty Images A group of drugmakers competing to bring a coronavirus vaccine to market plan to issue a public statement as soon… Read More »

Q&A with CIO Ryan Smith, Part 2: “We Need to Start Thinking About Vendors in a New Light.”

Ryan Smith, CIO, Intermountain Healthcare When Ryan Smith first started as a software engineer at Intermountain Healthcare, he probably wouldn’t have guessed he’d come back one day as CIO. But he did aspire to become someone who could “influence the direction of technology,” just as Larry Grandia (the organization’s first CIO) had. And he knew… Read More »